Eli Lilly
- Collected applications
- 1
- Share of collected applications with IPC
- 0.1%
Coverage is incomplete; counts and shares describe only the collected subset.
View Eli Lilly publications in this fieldCompany patentsCompare
HEAD TO HEAD
Eli LillyMetaTesla
Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.
+ Agricultural Bank of China2025-01 — 2025-12+ Alibaba2025-01 — 2025-12+ Alphabet (Google)2025-01 — 2025-12+ Amazon2025-01 — 2025-12+ Apple2025-01 — 2025-12+ Bank of China2025-01 — 2025-12+ BOE2024-01 — 2024-12+ Broadcom2025-01 — 2025-12+ BYD2024-01 — 2024-12+ CATL2024-01 — 2024-12+ China Construction Bank2025-01 — 2025-12+ China Mobile2025-01 — 2025-12+ CXMT2025-01 — 2025-12✓ Eli Lilly2025-01 — 2025-12+ Huawei2024-01 — 2024-12+ ICBC2025-01 — 2025-12✓ Meta2025-01 — 2025-12+ Microsoft2025-01 — 2025-12+ Midea2024-01 — 2024-12+ Kweichow Moutai2025-01 — 2025-12+ NVIDIA2025-01 — 2025-12+ PetroChina2025-01 — 2025-12+ SpaceX2025-01 — 2025-12+ Tencent2025-01 — 2025-12✓ Tesla2025-01 — 2025-12
Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds
This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.
Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.
Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY
Meta: Applicant names included in these statistics — FACEBOOK INC · META PLATFORMS INC · META PLATFORMS TECH LLCReviewed names not covered — FACEBOOK TECHNOLOGIES LLC · FACEBOOK, INC. · META PLATFORMS TECHNOLOGIES , LLC · META PLATFORMS TECHNOLOGIES LLC · META PLATFORMS TECHNOLOGIES, LLC · META PLATFORMS TECHNOLOGIES, LLC. · META PLATFORMS, INC. · OCULUS VR LLC
Tesla: Applicant names included in these statistics — TESLA INC · TESLA MOTORS INCReviewed names not covered — TESLA MOTORS, INC. · TESLA, INC.
Eli Lilly
- Publications
- 1,602
- Invention share
- 45%
- Concentration
- 0.73
- Green technology
- —
Meta
- Publications
- 1,545
- Invention share
- 97%
- Concentration
- 0.43
- Green technology
- —
Tesla
- Publications
- 609
- Invention share
- 91%
- Concentration
- 0.29
- Green technology
- —
0.01
Eli Lilly × Meta
0.01
Eli Lilly × Tesla
0.45
Meta × Tesla
01Technology field mirror
The 12 fields with the largest combined share. Share shows structure; count shows scale.
| Technology field | Eli Lilly / Meta / Tesla |
|---|---|
| Computer technology | 0.6% 49.3% 24.4% |
| Pharmaceuticals | 68.5% 0% 0% |
| Biotechnology | 39.9% 0% 0% |
| Electrical machinery, apparatus, energy | 0% 5.4% 33.6% |
| Optics | 0% 36.7% 1.7% |
| Transport | 0% 0% 31.6% |
| Organic fine chemistry | 25.8% 0% 0% |
| Audio-visual technology | 0.1% 17% 4.5% |
| Medical technology | 17.6% 2.5% 0.2% |
| Digital communication | 0.1% 12.4% 2.4% |
| Semiconductors | 0% 3.9% 6.2% |
| Measurement | 1% 4.1% 4.2% |
Inspect one technology field
Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.
Meta
- Collected applications
- 250
- Share of collected applications with IPC
- 17%
Coverage is incomplete; counts and shares describe only the collected subset.
View Meta publications in this fieldTesla
- Collected applications
- 27
- Share of collected applications with IPC
- 4.5%
Coverage is incomplete; counts and shares describe only the collected subset.
View Tesla publications in this fieldOne application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.
02Same problem: shared IPC subclasses
The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.
G06FData processing
Eli Lilly2
Meta541
Tesla85
G06TImage processing
Eli Lilly5
Meta307
Tesla21
G06VImage and video recognition
Eli Lilly2
Meta122
Tesla48
G06NComputing models, AI
Eli Lilly3
Meta41
Tesla66
B29C
Eli Lilly2
Meta5
Tesla5
03Where each one leans
Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.
Eli Lilly
- A61K
- Eli Lilly
- 926
- Meta
- —
- Tesla
- —
- A61P
- Eli Lilly
- 766
- Meta
- —
- Tesla
- —
- C07K
- Eli Lilly
- 454
- Meta
- —
- Tesla
- —
- C07DHeterocyclic compounds
- Eli Lilly
- 300
- Meta
- —
- Tesla
- —
- A61M
- Eli Lilly
- 196
- Meta
- —
- Tesla
- —
- C12NMicroorganisms, enzymes
- Eli Lilly
- 153
- Meta
- —
- Tesla
- —
Meta
- G02BOptical elements
- Eli Lilly
- —
- Meta
- 483
- Tesla
- 7
- G06FData processing
- Eli Lilly
- 2
- Meta
- 541
- Tesla
- 85
- G06TImage processing
- Eli Lilly
- 5
- Meta
- 307
- Tesla
- 21
- H04NPictorial communication, video
- Eli Lilly
- —
- Meta
- 135
- Tesla
- 5
- H04WWireless networks
- Eli Lilly
- 2
- Meta
- 101
- Tesla
- —
- H04LDigital transmission
- Eli Lilly
- —
- Meta
- 112
- Tesla
- 13
Tesla
- H01MBatteries, electrochemical cells
- Eli Lilly
- —
- Meta
- 18
- Tesla
- 115
- G06NComputing models, AI
- Eli Lilly
- 3
- Meta
- 41
- Tesla
- 66
- B60LElectric vehicle propulsion
- Eli Lilly
- —
- Meta
- —
- Tesla
- 36
- B62DBodies, chassis
- Eli Lilly
- —
- Meta
- —
- Tesla
- 36
- B60WVehicle sub-unit control
- Eli Lilly
- —
- Meta
- —
- Tesla
- 35
- B60RVehicle electrics, fittings
- Eli Lilly
- —
- Meta
- —
- Tesla
- 30
04Publication rhythm
| Period | Eli Lilly | Meta | Tesla |
|---|---|---|---|
| 2025-01 | ≥118 (partial coverage) | ≥116 (partial coverage) | ≥57 (partial coverage) |
| 2025-02 | ≥121 (partial coverage) | ≥146 (partial coverage) | ≥37 (partial coverage) |
| 2025-03 | ≥158 (partial coverage) | ≥163 (partial coverage) | ≥27 (partial coverage) |
| 2025-04 | ≥110 (partial coverage) | ≥153 (partial coverage) | ≥43 (partial coverage) |
| 2025-05 | ≥134 (partial coverage) | ≥142 (partial coverage) | ≥60 (partial coverage) |
| 2025-06 | ≥140 (partial coverage) | ≥124 (partial coverage) | ≥58 (partial coverage) |
| 2025-07 | ≥138 (partial coverage) | ≥123 (partial coverage) | ≥52 (partial coverage) |
| 2025-08 | ≥134 (partial coverage) | ≥130 (partial coverage) | ≥56 (partial coverage) |
| 2025-09 | ≥132 (partial coverage) | ≥94 (partial coverage) | ≥52 (partial coverage) |
| 2025-10 | ≥155 (partial coverage) | ≥153 (partial coverage) | ≥56 (partial coverage) |
| 2025-11 | ≥140 (partial coverage) | ≥102 (partial coverage) | ≥54 (partial coverage) |
| 2025-12 | ≥122 (partial coverage) | ≥99 (partial coverage) | ≥57 (partial coverage) |
Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.
Publication timing follows examination and publication cycles, not R&D intensity.
What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.
What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.
Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.